Sign inJoin waitlistJoin the waitlist

Uqba Khan

Assistant Professor of Clinical Medicine, Division of Hematology and Medical Oncology · Weill Cornell Medicine

Credentials: · · · · · ·

History

Weill Cornell Medicine
2019–Present

Hematology and Medical Oncology
Henry Ford St. John Hospital
2026–Present
Weill Cornell Medicine
2018–2019
Internal Medicine
St Agnes HealthCare
2013–2016
St. Agnes Hospital
2012–2013
Allama Iqbal Medical College
2004–2008

Research

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline
Systematic review or meta-analysis · Journal of Clinical Oncology · 2023 · 194 citations
T Lymphocytes and Autoimmunity
Review · International review of cell and molecular biology · 2018 · First of 2 authors · 100 citations
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma
Cancers · 2021 · 75 citations

AS
Anwaar Saeed
12 papers
Celina Ang
11 papers
Thomas Marron
11 papers
Ahmed Kaseb
10 papers
Hannah Hildebrand
10 papers · 3 as a resident
Mahvish Muzaffar
10 papers
SD
Sirish Dharmapuri
10 papers
TJ
Tomi Jun
10 papers · 7 as a fellow
Manish Shah
9 papers
SP
Sonal Paul
9 papers · 9 as a fellow
Yinghong Wang
9 papers
Abdul Naqash
8 papers · 2 as a fellow

Clinical trials

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Site PI · Recruiting · Phase 2
Alliance for Clinical Trials in Oncology
2023–2032
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2023–2028
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Site PI · Recruiting · Phase 2, Phase 3
NRG Oncology
2022–2030